Kaddoura, Malak published the artcileCOVID-19 therapeutic options under investigation, Computed Properties of 55981-09-4, the main research area is review human covid19 virus immunomodulator; COVID-19; SARS-CoV-2; adjunctive therapy; antivirals; therapeutics.
Since its emergence in China in Dec. 2019, COVID-19 has quickly spread around the globe causing a pandemic. Vaccination or the development of herd immunity seems the only way to slow down the spread of the virus; however, both are not achievable in the near future. Therefore, effective treatments to mitigate the burden of this pandemic and reduce mortality rates are urgently needed. Preclin. and clin. studies of potential antiviral and immunomodulatory compounds and mols. to identify safe and efficacious therapeutics for COVID-19 are ongoing. Two compounds, remdesivir, and dexamethasone have been so far shown to reduce COVID-19-associated death. Here, we provide a review of the potential therapeutic agents being considered for the treatment and management of COVID-19 patients.
Frontiers in Pharmacology published new progress about COVID-19. 55981-09-4 belongs to class esters-buliding-blocks, name is 2-((5-Nitrothiazol-2-yl)carbamoyl)phenyl acetate, and the molecular formula is C12H9N3O5S, Computed Properties of 55981-09-4.
Referemce:
Ester – Wikipedia,
Ester – an overview | ScienceDirect Topics